piperazine has been researched along with Granulocytic Leukemia, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saab, AM | 1 |
| Dobmeier, M | 1 |
| Koenig, B | 1 |
| Fabri, E | 1 |
| Finotti, A | 1 |
| Borgatti, M | 1 |
| Lampronti, I | 1 |
| Bernardi, F | 1 |
| Efferth, T | 1 |
| Gambari, R | 1 |
| Pan, X | 1 |
| Dong, J | 1 |
| Shi, Y | 1 |
| Shao, R | 1 |
| Wei, F | 1 |
| Wang, J | 1 |
| Zhang, J | 1 |
| Hopkin, MD | 1 |
| Baxendale, IR | 1 |
| Ley, SV | 1 |
3 other studies available for piperazine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Antiproliferative and erythroid differentiation of piperazine and triphenyl derivatives against k-562 human chronic myelogenous leukemia.
Topics: Cell Death; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergi | 2013 |
Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.
Topics: Acylation; Antineoplastic Agents; Cell Proliferation; Drug Discovery; Fusion Proteins, bcr-abl; Huma | 2015 |
A flow-based synthesis of imatinib: the API of Gleevec.
Topics: Antineoplastic Agents; Benzamides; Dimethylamines; Humans; Imatinib Mesylate; Leukemia, Myelogenous, | 2010 |